---
title: "Intuitive Surgical, Inc. (ISRG.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/ISRG.US.md"
symbol: "ISRG.US"
name: "Intuitive Surgical, Inc."
industry: "Health Care Equipment"
datetime: "2026-05-19T19:14:06.540Z"
locales:
  - [en](https://longbridge.com/en/quote/ISRG.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ISRG.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ISRG.US.md)
---

# Intuitive Surgical, Inc. (ISRG.US)

## Company Overview

Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights.

| Item | Detail |
|------|--------|
| Industry | Health Care Equipment |
| Exchange | US Market |
| Website | [www.intuitive.com](https://www.intuitive.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: B
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-19T04:30:14.000Z

**Overall: B (0.26)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 3 / 183 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Growth - Stocks whose main business is in the growth stage.
- **Scale**: Large - The company has stable operations, allowing for dependable long-term returns.

**Multi Score**: B

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 21.43% |  |
| Net Profit YoY | 20.31% |  |
| P/B Ratio | 8.92 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 155803317452.64 |  |
| Revenue | 10582100000.00 |  |

#### Multi Score Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 17.23% | A |
| Profit Margin | 28.15% | A |
| Gross Margin | 66.06% | A |
| Revenue YoY | 21.43% | B |
| Net Profit YoY | 20.31% | B |
| Total Assets YoY | 4.63% | C |
| Net Assets YoY | 2.26% | C |
| Cash Flow Margin | 112.81% | C |
| OCF YoY | 21.43% | B |
| Turnover | 0.54 | C |
| Gearing Ratio | 12.50% | A |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Intuitive Surgical, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "21.43%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "20.31%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "8.92",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "155803317452.64",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "10582100000.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "17.23%",
          "rating": "A"
        },
        {
          "name": "Profit Margin",
          "value": "28.15%",
          "rating": "A"
        },
        {
          "name": "Gross Margin",
          "value": "66.06%",
          "rating": "A"
        },
        {
          "name": "Revenue YoY",
          "value": "21.43%",
          "rating": "B"
        },
        {
          "name": "Net Profit YoY",
          "value": "20.31%",
          "rating": "B"
        },
        {
          "name": "Total Assets YoY",
          "value": "4.63%",
          "rating": "C"
        },
        {
          "name": "Net Assets YoY",
          "value": "2.26%",
          "rating": "C"
        },
        {
          "name": "Cash Flow Margin",
          "value": "112.81%",
          "rating": "C"
        },
        {
          "name": "OCF YoY",
          "value": "21.43%",
          "rating": "B"
        },
        {
          "name": "Turnover",
          "value": "0.54",
          "rating": "C"
        },
        {
          "name": "Gearing Ratio",
          "value": "12.50%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 52.30 | 40/183 | 74.15 | 65.57 | 59.68 |
| PB | 8.92 | 122/183 | 11.56 | 9.95 | 9.19 |
| PS (TTM) | 14.72 | 123/183 | 21.15 | 18.67 | 17.01 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Delcath (DCTH.US) | C | A | B | A | A | A |
| 02 | Electromed (ELMD.US) | A | B | A | A | B | A |
| 03 | Intuitive Surgical (ISRG.US) | A | B | C | A | B | B |
| 04 | Stryker (SYK.US) | A | C | C | C | B | B |
| 05 | Boston Scientific (BSX.US) | A | B | C | C | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-18T04:00:00.000Z

Total Analysts: **33**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 16 | 48% |
| Overweight | 6 | 18% |
| Hold | 10 | 30% |
| Sell | 1 | 3% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 442.27 |
| Highest Target | 750.00 |
| Lowest Target | 378.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/ISRG.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/ISRG.US/norm.md)
- [Related News](https://longbridge.com/en/quote/ISRG.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/ISRG.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**